INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
May 29, 2024
Document Date
May 28, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
BROWN MICHAEL S